Développement de fabrication d’un comprimé Pergus ® 10 mg

Saoudi, Roufaida; Bachir, Cherif Khadidja

dc.contributor.author	Saoudi, Roufaida
dc.contributor.author	Bachir, Cherif Khadidja
dc.date.accessioned	2023-10-11T09:36:13Z
dc.date.available	2023-10-11T09:36:13Z
dc.date.issued	2023
dc.identifier.uri	https://di.univ-blida.dz/jspui/handle/123456789/25513
dc.description	4.540.1.1123/p68	fr_FR
dc.description.abstract	The aim of this work is to develop the galenic form of a generic drug, PERGUS®, in the form of coated immediate-release tablets, based on Prasugrel (active ingredient) at a dose of 10mg. The manufacturing development was carried out successively on powder mixing, dry granulation, grain compaction, grinding, compression and finally tablet coating. Quality control of production intermediates and semi-finished products was carried out in accordance with European pharmacopoeia standards. Pharmaco-technical and physico-chemical tests have shown satisfactory results and compliance with the specifications required by the European Pharmacopoeia. The generic PERGUS® 10mg was successfully developed using a galenic process and reliable, reproducible analytical and biopharmaceutical techniques.	fr_FR
dc.language.iso	fr	fr_FR
dc.publisher	blida 1	fr_FR
dc.subject	Galenic development, dry granulation, coated tablets, generic drug, quality control, Pharmacopoeia.	fr_FR
dc.title	Développement de fabrication d’un comprimé Pergus ® 10 mg	fr_FR
dc.type	Other	fr_FR